Myeloma research group
1 – 10 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus
Linge, Petrus LU ; Arve, Sabine LU
; Olsson, Lina M.
; Leonard, Dag
; Sjöwall, Christopher
; Frodlund, Martina
; Gunnarsson, Iva
; Svenungsson, Elisabet
; Tydén, Helena
LU
and Jönsen, Andreas
LU
, et al.
(2020)
In Annals of the Rheumatic Diseases
79(2).
p.254-261
Mark
- Genetic predisposition for multiple myeloma
- Search for multiple myeloma risk factors using Mendelian randomization
- Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels
- Outcome and characteristics of non-measurable myeloma : A cohort study with population-based data from the Swedish Myeloma Registry
- Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression : A prospective, open-label, multicenter, randomized, phase 3 study
-
Increased Frequencies of Switched Memory B Cells and Plasmablasts in Peripheral Blood from Patients with ANCA-Associated Vasculitis
Elmér, Evelina LU
; Smargianaki, Sofia
LU
; Pettersson, Åsa
LU
; Skattum, Lillemor
LU
; Ohlsson, Sophie
LU
; Hellmark, Thomas
LU
and Johansson, Åsa C M
LU
(2020)
In Journal of Immunology Research
2020.
Mark
- 2019
-
Aspects of Phagocyte Function in Multiple Myeloma
Wichert, Stina LU
(2019)
In Lund University, Faculty of Medicine Doctoral Dissertation Series
2019(8).
Mark
- All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
- Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden